For the pur- poses of full transparency, the writing group members comprehensive disclosure information is available online. 1.3. Document Review and Approval This document was reviewed by the AHA s Stroke Coun- cil Scientific Statement Oversight Committee; the AHA s Science Advisory and Coordinating Committee; the AHA s Executive Committee; reviewers from the Ameri- can Academy of Neurology, from the Society of Vascu- lar and Interventional Neurology, and from the American Association of Neurological Surgeons and Congress of Neurological Surgeons; as well as by 55 individual con- tent reviewers. The individual reviewers relationships with industry information is available in Appendix 2. This document was approved for publication by the governing bodies of the ASA and the AHA. It was reviewed for evidence-based integrity and endorsed by the American Association of Neurological Surgeons and Congress of Neurological Surgeons, was endorsed by the Society of Vascular and Interventional Neurology, and the American Academy of Neurology affirmed the value of the guideline. CLINICAL STATEMENTS AND GUIDELINES Kleindorfer 1.4. Scope of the Guideline The aim of the present guideline is to provide clinicians with evidence-based recommendations for the preven- tion of future stroke among survivors of ischemic stroke or TIA. 